Kyung-Min Lee

9PUBLICATIONS
41CO-AUTHORS
Biologically active moleculesMolecular targetsCancer cell biologyPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang

|Feb 25, 2023
Special Issue: Resistance to Targeted Therapies in Human Cancer.

Tae-Won Lee, Hee-Joo Choi, Kyung-Min Lee

|Jul 05, 2022
ECM1 is associated with endocrine resistance in ER+ breast cancers.

Tae Won Lee, Kyung-Min Lee

Pageof 2